Silo Pharma Inc SILO

Healthcare Biotechnology

Silo Pharma, Inc. is a developmental stage biopharmaceutical company. The Company is focused on developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It is engaged in acquiring and/or developing intellectual property or technology rights from universities and researchers to treat rare diseases, including the use of psychedelic drugs, such as psilocybin, and the potential benefits they may have in certain cases involving depression, mental health issues and neurological disorders. The Company’s lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders. Its SP-26 is a time-release ketamine-loaded implant for fibromyalgia and chronic pain relief. Its two preclinical programs are SPC-14, an intranasal compound for the treatment of Alzheimer’s disease, and SPU-16, a CNS-homing peptide targeting multiple sclerosis (MS).

NDAQ:SILO - Post by User

Silo Pharma Inc

<< Previous

Bullboard Posts

Next >>

Post by coolfooldumbguyon Jul 16, 2024 11:53am

38 Views

Post# 36134826

This stock is still cheap.

Got some this morning at $1.98 per share at 10:35 A.M. It is a hold for me until year end.This stock is not a day trade. You should die your own due diligence,so glta.

<< Previous

Bullboard Posts

Next >>

Rig Count Soars as Utilization Surpasses Industry Averages